Clinical characteristics of linezolid-resistant Staphylococcus aureus infections

被引:52
|
作者
Peeters, MJ
Sarria, JC
机构
[1] Univ Texas, Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Lubbock, TX 79430 USA
来源
关键词
D O I
10.1097/00000441-200508000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Case reports have previously identified linezolid resistance in 6 clinical isolates of Staphylococcus aureus. We describe an additional case and discuss clinical characteristics of these patients. Invasive procedures, deep organ involvement, and presence of foreign material were predominant in these cases. Resistance followed prolonged (>21 days) linezolid therapy in most cases. The development of resistance to linezolid should be taken into account when selecting this drug as a therapeutic option.
引用
收藏
页码:102 / 104
页数:3
相关论文
共 50 条
  • [1] Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus
    Meka, VG
    Gold, HS
    Cooke, A
    Venkataraman, L
    Eliopoulos, GM
    Moellering, RC
    Jenkins, SG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) : 818 - 820
  • [2] Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
    Sanchez Garcia, Miguel
    Angeles De la Torre, Maria
    Morales, Gracia
    Pelaez, Beatriz
    Jose Tolon, Maria
    Domingo, Sara
    Javier Candel, Francisco
    Andrade, Raquel
    Arribi, Ana
    Garcia, Nicolas
    Martinez Sagasti, Fernando
    Fereres, Jose
    Picazo, Juan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (22): : 2260 - 2264
  • [3] Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis
    Yu, Diana
    Stach, Leslie M.
    Newland, Jason G.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (04) : E163 - E165
  • [4] Emergence of linezolid-resistant methicillin-resistant Staphylococcus aureus in Japan
    Hanaki, H.
    Yanagisawa, C.
    Hososaka, Y.
    Ishibashi, K.
    Yamamoto, S.
    Imamura, Y.
    Taniwaki, S.
    Nakae, T.
    Sunakawa, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S519 - S519
  • [5] Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo
    Kaul, Grace
    Akhir, Abdul
    Shukla, Manjulika
    Rawat, Kundan S.
    Sharma, Chandra P.
    Sangu, Komal G.
    Rode, Haridas B.
    Goel, Atul
    Chopra, Sidharth
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (09) : 2456 - 2460
  • [7] Parallel evolution of linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
    Pitcher, Nicholas J.
    Feder, Andries
    Bolden, Nicholas
    Zirbes, Christian F.
    Pamatmat, Anthony J.
    Boyken, Linda
    Hill, Jared J.
    Bartels, Alyssa R.
    Thurman, Andrew L.
    Reeb, Valerie C.
    Porterfield, Harry S.
    Moustafa, Ahmed M.
    Planet, Paul J.
    Fischer, Anthony J.
    MICROBIOLOGY SPECTRUM, 2023,
  • [8] Parallel evolution of linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
    Pitcher, Nicholas J.
    Feder, Andries
    Bolden, Nicholas
    Zirbes, Christian F.
    Pamatmat, Anthony J.
    Boyken, Linda
    Hill, Jared J.
    Bartels, Alyssa R.
    Thurman, Andrew L.
    Reeb, Valerie C.
    Porterfield, Harry S.
    Moustafa, Ahmed M.
    Planet, Paul J.
    Fischer, Anthony J.
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [9] Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus
    Baos, Elvira
    Javier Candel, Francisco
    Merino, Paloma
    Pena, Irene
    Jose Picazo, Juan
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (03) : 325 - 329
  • [10] Linezolid-resistant Staphylococcus capitis isolate
    Ibrahim, R.
    Waked, R.
    Choucair, J.
    Aubry, A.
    Laurent, F.
    Simoes, P. Martins
    Dupieux-Chabert, C.
    Haddad, E.
    INFECTIOUS DISEASES NOW, 2022, 52 (03): : 176 - 177